1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

ActiveNational Institute on Deafness and Other Communication Disorders (NIDCD) / NIH Fogarty International Center · 2026

Emerging Global Leader Award (K43)

Quick Facts

Agency: National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH Fogarty International Center
Funding: See official notice
Deadline: December 3, 2026 (71 days remaining)
Status: Active
Eligibility: Early career investigators who are citizens of and currently residing and working in a low- or middle-income country, including Argentina.
Grant Type: Fellowship
Geographic Scope: International

VerifiedGrant verified by AI review

✓ Award amounts confirmed

About This Grant

Emerging Global Leader Award (K43) is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH Fogarty International Center. This award supports early career investigators in low- and middle-income countries who are poised to become independent research leaders in global health. It provides protected time for research and career development.

Visit Program Page

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Emerging Global Leader Award (K43) - Fogarty International Center @ NIH Emerging Global Leader Award Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-24-295) Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-24-296) Only low- or middle-income country (LMIC) institutions are eligible. Income categories are defined by The World Bank Country and Lending Groups .

Country eligibility for Fogarty International Training Grants applies.

Eligibility for applications with Independent Clinical Trials (PAR-24-295) Eligibility for applications without Independent Clinical Trials (PAR-24-296) Answers to frequently asked questions (FAQs) The Fogarty Emerging Global Leader Award aims to provide research support and protected time to a research scientist from a LMIC who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution.

Low-income, lower-middle-income and upper-middle-income countries are included. Applications are invited from LMIC research scientists from any health-related discipline who propose both critically needed career development activities and a research project that is highly relevant to the health priorities of their country. View a list of Emerging Global Leader awards by institution.

Fogarty International Center National Institutes of Health Grants Management Specialist Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 This announcement is issued by Fogarty in collaboration with the following NIH Institutes and Centers: National Cancer Institute (NCI) National Eye Institute (NEI) National Human Genome Research Institute (NHGRI) National Heart, Lung, and Blood Institute (NHLBI) National Institute on Aging (NIA) National Institute on Drug Abuse (NIDA) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute on Dental and Craniofacial Research (NIDCR) National Institute of Environmental Health Sciences (NIEHS) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) NIH Office of Research on Women's Health (ORWH) Grant recipient news: Celebrating our emerging global leaders in health sciences University of Cape Town news, September 9, 2024 Hepatitis B surface antigen loss in individuals with chronic hepatitis B virus and HIV-1 infections in Botswana , co-authored by Fogarty grant recipients Roger Shapiro, Joseph Makhema, and Shahin Lockman, Fogarty Emerging Global Leader Sikhulile Moyo, and Fogarty trainees Mompati Mmalane and Simani Gaseitsiwe Gaps and Opportunities for Strengthening In-School Support for Youth Living With HIV , co-authored by Fogarty Emerging Global Leader Irene Njuguna The Journal of School Health , February 2024 Defining the usefulness of oral swabs in tuberculosis diagnosis , co-authored by Fogarty Emerging Global Leader Marieke M.

van Der Zalm The Lancet Global Health , January 1, 2024 Podcast: Improving Access to Vaccines in Children , featuring Fogarty Emerging Global Leader Oghenebrume Wariri ImmunoAfrica podcast, January 28, 2024 Utilization of opportunistic cervical cancer screening in Nigeria , co-authored by Fogarty Emerging Global Leader Jonah Musa Cancer Causes and Control , January 2024 Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana , co-authored by Fogarty grantees Joseph Makhema, Roger Shapiro, and Shahin Lockman, Fogarty Emerging Global Health Leader Sikhulile Moyo, and Fogarty trainees Ontlametse Bareng, Terence Mohammed, and Catherine Koofhethile Scientific Reports , October 24, 2023 Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use , co-authored by Fogarty Emerging Global Leader Sikhulile Moyo, Fogarty grant recipients Joseph Makhema, Roger Shapiro, and Shahin Lockman, and Fogarty trainees Ontlametse Bareng, Patrick Mokgethi, Kaelo Seatla, Catherine Koofhethille, and Simani Gaseitsiwe The Journal of Antimicrobial Chemotherapy , October 3, 2023 This researcher wants to normalize mental health care in Ukraine Global Health Matters , September/October 2023 Dr. Anthony Batte wins the NIH Emerging Global Leaders Award Makerere University news, August 29, 2023 Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 Pandemic , co-authored by Emerging Global Leader Marieke Van Der Zalm Pediatric Infectious Disease Journal , August 2023 Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria , co-authored Emerging Global Leader John Musa BMC Cancer , July 20, 2023 Human testing for potential new TB treatment, first in nearly six decades profile of Fogarty Emerging Global Leader Admire Dube, Nature Africa , June 27, 2023 Employing user-centered design to fill gaps in mental health treatment : Q&A with Emerging Global Leader Lola Kola Global Health Matters , Nov/Dec 2022 Oral health researchers welcome here!

– Opinion by Fogarty Director Dr. Roger I.

Glass Emerging and re-emerging fungal threats in Africa , Fogarty grantee Sean Wasserman co-author Parasite Immunology , September 29, 2022 Emerging Global Leader/Fogarty Fellow Dr. Siana Nkya tackles sickle cell disease in Tanzania Global Health Matters , May/June 2022 Dr. Veronica Dzomeku hopes to transform maternity care in Ghana Global Health Matters , Nov/Dec 2021 Emerging Global Leader/NCI grantee Dr Simone Badal addresses inequities in prostate cancer Grantee spotlight: Dr Simone Badal Novel prostate cancer cell lines to address prostate cancer disparity in Black men Spotlight blog, May 27, 2021 Fogarty allocates $4M to support early-career scientists Emerging Global Leader grantee Dr Manasi Kumar studies COVID impact on pregnant teens in Kenya Fogarty awards $10M for early-career researchers to establish independent careers in global health Dr Leopold Tientcheu Djomkam wins the K43 Emerging Global Leader Award MRC Unit The Gambia/LSTMH news, Oct 2018 Stopping malnutrition in its tracks Aga Khan University news, Nov 27, 2017 Emerging global health leaders receive $5M in research support Fogarty news, November 16, 2017 NIH awards $3M to support emerging research leaders in developing countries Fogarty news, August 4, 2016 Career Award (K) Policy Update: Concurrent Support from a Mentored K Award and a Research Grant (NOT-OD-18-157) , released April 6, 2018 Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)” (NOT-DC-23-007) , released April 6, 2023 Notice of letter of intent guidance for PAR-19-098 and PAR-19-051 ( NOT-TW-19-001 ), released January 11, 2019

Eligibility Requirements

Early career investigators who are citizens of and currently residing and working in a low- or middle-income country, including Argentina.

Frequently Asked Questions

Who can apply for Emerging Global Leader Award (K43)?

According to the current listing, eligibility includes: Early career investigators who are citizens of and currently residing and working in a low- or middle-income country, including Argentina. Confirm the full requirements in the official notice before applying.

When is the deadline for Emerging Global Leader Award (K43)?

Applications for Emerging Global Leader Award (K43) are due December 3, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.

Who funds Emerging Global Leader Award (K43)?

Emerging Global Leader Award (K43) is funded by National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH Fogarty International Center. Verify program details on the funder's official page before applying.

Is Emerging Global Leader Award (K43) open internationally?

This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.

How do I apply for Emerging Global Leader Award (K43)?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

U.S. Mission to Panama

Grants.govDeadline Passed

Equipping Journalists to Counter Anti-American Propaganda

The U.S. Department of State’s Embassy Panama announces an open competition to design and implement a program to strengthen Panamanian journalists’ English language proficiency, applied AI skills, and digital media literacy in order to counter disinformation and advance a more informed public discourse.Panama’s media environment faces growing challenges from disinformation and external influence campaigns that threaten reliable public discourse. This one-year program combines advanced English language instruction with applied artificial intelligence (AI) training and digital media literacy skills, enabling participants to access credible English-language sources, evaluate information critically, and use emerging technologies responsibly in their reporting.By the program’s end, participants will demonstrate improved English proficiency and enhanced digital literacy, enabling them to engage with U.S. expertise and global media resources. They will also apply these skills to identify manipulated media, AI-generated content, and disinformation, and to use fact-checking and verification techniques, effectively strengthening their credibility as trusted, reliable messengers for their communities.This initiative directly advances U.S. foreign policy priorities by countering anti-American propaganda and building resilience against digital disinformation threats, fostering a more informed public discourse in Panama and reinforcing trust in credible, fact-based reporting aligned with U.S. interests in the region. Funding Opportunity Number: PDS-PAN-FY26-02. Assistance Listing: 19.040. Funding Instrument: G. Category: RD. Award Amount: $25K – $120K per award.

$25K – $120K per awardDeadline: Sep 13, 2026 (passed)

National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH Fogarty International Center Grant Writing Tips

ARPA-H's Autism Program Staggered Its Deadlines Across Three Months. The Order Tells You What It Wants First.

ARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.

Read article

NIH Is Collapsing 14 K Awards Into Four — and Quietly Ending the Independent Clinical Trial K

NOT-OD-26-098 consolidates NIH career development awards into four parent NOFOs (KR1, KC1, KS1, KT1), eliminates the Data Management and Sharing Plan for K applications, and stops supporting K awards that let the awardee lead their own clinical trial. The RFI closes September 30, 2026; the new structure hits due dates on or after October 12, 2027.

Read article

DOE's $215M Quantum Q Competition Has a $250,000 Entry Ticket and a $200M Ceiling. Read the Instrument Before the Number.

The DOE Quantum Genesis Q Competition (DE-FOA-0003657) posted September 17, 2026 with an October 19 deadline. Phase I pays $250,000 then $1.25M on milestones; Phase II is a $100M pool plus two $50M bonus pools at 150 and 200 logical qubits. It is an Other Transaction Agreement, not a grant.

Read article